Atlas Trials

Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

Clinical trial NCT04690335 · COMPLETED

Trial details

NCT number
NCT04690335
Sponsor
Meissa Vaccines, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
RSV Infection
Start date
2020-12-29
Primary completion
2021-05-07
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.